Inclusion Criteria:  Adult patient Effective contraception for the duration of research for fertile women of childbearing age Unilateral Rutherford 2 or 3 symptomatic LEAD (Lower extremity artery disease) arteritic patient with a lesion of the superficial femoral artery TASC (Trans-Atlantic Inter-Society Consensus) C or D between 15 and 25 cm Patient eligible for bypass surgery and endovascular procedure No alteration of the upstream flow (iliac flow preserved or restored) Patient with at least one patent artery below the knee Patient informed and having signed the information and consent form to participate in the study  Exclusion Criteria:  Known pregnancy or breastfeeding Iliac flow altered upstream History of surgery or stent on the affected superficial femoral artery Concomitant bacteremia (positive blood cultures in the 7 days preceding the procedure) Known intolerance to antiaggregants or heparin Contraindication to the endovascular procedure (severe renal failure contraindicating the injection of contrast product despite prior hydration, known severe allergy to iodinated contrast product) or bypass surgery (cardiovascular, respiratory or other comorbidities, contraindicating general anesthesia, local contraindications for bypass: skin lesion at the operative site) No affiliation to a social security regime or to another social protection regime No affiliation to a social security scheme or to another social protection scheme Patient deprived of liberty or under legal protection (guardianship, trusteeship) Inability, according to the investigator, to understand or refusal to sign the informed consent to participate in the study (non-French speaking patient, cognitive disorders) Ongoing participation in another research protocol Participation in non-interventional research is authorized  Secondary exclusion criterion:  β-HcG (chorionic gonadotropic hormone) positive preoperative laboratory test (results received after obtaining consent, but before randomization)